Synthesis, identification, characterization, stability, solubility, and protein binding of ester derivatives of salicylic acid and diflunisal

[1]  G. Mellick,et al.  The Disposition of Aspirin and Salicylic Acid in the Isolated Perfused Rat Liver: the Effect of Normal and Retrograde Flow on Availability and Mean Transit Time , 1996, The Journal of pharmacy and pharmacology.

[2]  C. Ji,et al.  Acetylation of human prostaglandin endoperoxide synthase-2 (cyclooxygenase-2) by aspirin. , 1994, The Journal of biological chemistry.

[3]  A. Beezer,et al.  The importance of chain length on the wettability and solubility of organic homologs , 1991 .

[4]  J. Vial,et al.  Selective inhibition of platelet cyclooxygenase with controlled release, low-dose aspirin. , 1990, Australian and New Zealand journal of medicine.

[5]  M. Wientjes,et al.  Nonlinear pharmacokinetics of aspirin in rats. , 1988, The Journal of pharmacology and experimental therapeutics.

[6]  M. S. Roberts,et al.  Low-dose enteric-coated aspirin as an antiplatelet preparation. , 1988, The Medical journal of Australia.

[7]  D. Kilpatrick,et al.  Extrahepatic metabolism and distribution of aspirin in vascular beds of sheep. , 1986, Journal of pharmaceutical sciences.

[8]  D. Kilpatrick,et al.  Distribution and metabolism of nitroglycerin and its metabolites in vascular beds of sheep. , 1986, The Journal of pharmacology and experimental therapeutics.

[9]  R. M. Joyce,et al.  SLOW-RELEASE ASPIRIN AND PROSTAGLANDIN INHIBITION , 1986, The Lancet.

[10]  F. Bochner,et al.  Aspirin kinetics and platelet aggregation in man , 1983, Clinical pharmacology and therapeutics.

[11]  K. Iwamoto,et al.  Gastrointestinal and hepatic first‐pass metabolism of aspirin in rats , 1982, The Journal of pharmacy and pharmacology.

[12]  P. Clifton,et al.  Aspirin binding and the effect of albumin on spontaneous and enzyme‐catalysed hydrolysis , 1980, The Journal of pharmacy and pharmacology.

[13]  J. Thiessen,et al.  Plasma Acetylsalicylate and Salicylate and Platelet Cyclooxygenase Activity Following Plain and Enteric‐Coated Aspirin , 1980, Stroke.

[14]  A. Yacobi,et al.  Comparative pharmacokinetics of coumarin anticoagulants XXI: effect of plasma protein binding on distribution kinetics of warfarin in rats. , 1977, Journal of pharmaceutical sciences.

[15]  C Silipo,et al.  Calculation of hydrophobic constant (log P) from pi and f constants. , 1975, Journal of medicinal chemistry.

[16]  S. Davis,et al.  Determination of thermodynamics of the methylene group in solutions of drug molecules. , 1972, The Journal of pharmacy and pharmacology.

[17]  S. Yalkowsky,et al.  Importance of chain length on physicochemical and crystalline properties of organic homologs. , 1972, Journal of pharmaceutical sciences.

[18]  S. Davis,et al.  Suggested thermodynamic standard state for comparing drug molecules in structure-activity studies. , 1972, Journal of pharmaceutical sciences.

[19]  Pask Ea,et al.  HAZARDS IN THE GAS INDUSTRY. , 1965 .

[20]  S. Yalkowsky.  Techniques of solubilization of drugs , 1981 .

[21]  W J Jusko,et al.  Plasma and tissue protein binding of drugs in pharmacokinetics. , 1976, Drug metabolism reviews.

[22]  S. Riegelman,et al.  Influence of the route of administration on the area under the plasma concentration-time curve. , 1969, Journal of pharmaceutical sciences.

[23]  G. A. Levvy,et al.  CHAPTER 4 – β-Glucuronidase and the Hydrolysis of Glucuronides , 1966 .

[24]  L. Hammett,et al.  Physical organic chemistry , 1940 .